Equities

Danimer Scientific Inc

Danimer Scientific Inc

Actions
  • Price (EUR)9.44
  • Today's Change-0.12 / -1.26%
  • Shares traded0.00
  • 1 Year change-82.76%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5963286
Total Receivables, Net192425
Total Inventory253325
Prepaid expenses4.715.234.74
Other current assets, total------
Total current assets108125340
Property, plant & equipment, net464473335
Goodwill, net--063
Intangibles, net788185
Long term investments------
Note receivable - long term313113
Other long term assets2.210.231.62
Total assets698712839
LIABILITIES
Accounts payable5.291521
Accrued expenses7.517.6722
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.371.970.36
Other current liabilities, total1.550.670.21
Total current liabilities162543
Total long term debt381286261
Total debt383288261
Deferred income tax00.201.01
Minority interest------
Other liabilities, total232333
Total liabilities420335338
SHAREHOLDERS EQUITY
Common stock0.010.010.01
Additional paid-in capital732676619
Retained earnings (accumulated deficit)(454)(299)(119)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity278378500
Total liabilities & shareholders' equity698712839
Total common shares outstanding2.572.552.52
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.